Clicky

Tetra Bio-Pharma Inc.(TBPMF)

Description: Tetra Bio-Pharma Inc., a development stage company, engages in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements in Canada. The company offers Rx Princeps, a pharmaceutical-grade product based on its blend of smokable dried cannabis inhalation device. Its product pipeline includes PPP001, a dried cannabis prescription drug for advanced cancer pain; PPP002, a slow release formulation of Dronabinol for treating chemotherapy induced and chronic pain; PPP003, an ocular formulation of cannibinoids for the treatment of ocular pain and inflammation; PPP004, a topical cream for neuropathic pain; and PPP005, a cannabis oil capsule for the treatment of chronic pain. The company is also developing natural health products, including AGT001, a topical product for pain management; AGT002, an oral product line for cardiovascular disease prevention, athletic performance, and well-being; AGT003, a topical product for skin care; AGT004, a topical product for women; and Munchies B Gone gum. Tetra Bio-Pharma Inc. has a license and development agreement with IntelGenx Corp. for the development and commercialization of a drug product containing dronabinol; and Panag Pharma Inc. for the license and development of ocular and topical drugs. It also has research and development agreement with Constance Therapeutics, Inc. for the manufacture, process, prepare, study, research, and engage in clinical trials using the licensed products; co-development, marketing, and commercialization agreements with Neptune Technologies & Bioressources Inc. and Storz & Bickel; and strategic partnership with Sirius Air Solutions Inc. for suppling a specialized cannabis smoke air purifying system and a mask designed for law and emergency responders. The company was formerly known as GrowPros Cannabis Ventures Inc. and changed its name to Tetra Bio-Pharma Inc. in September 2016. Tetra Bio-Pharma Inc. is headquartered in Orleans, Canada.


Keywords: Medicine Clinical Medicine Pain Cannabis Health Sciences Entheogens Euphoriants Medicinal Plants Medical Cannabis Partnership Inflammation Chemotherapy Pain Management Cardiovascular Disease Chronic Pain Neuropathic Pain Antiemetics Appetite Stimulants Cannabis Oil Licensed Products Natural Health Product Natural Health Products Natural Health Bio Pharmaceutical Sirius Bio Pharmaceuticals Advanced Cancer Dronabinol Oil Capsule Cardiovascular Disease Prevention Pharmaceutical Grade Product Topical Product

Home Page: www.tetrabiopharma.com

2316 St. Joseph Boulevard
Orléans, ON K1C 1E8
Canada
Phone: 343 780 2020


Officers

Name Title
Dr. Guy Chamberland M.Sc., Master Herbal Co-Founder, CEO, Chief Regulatory Officer & Director
Mr. Steeve Néron Chief Commercial Officer
Mr. André Rancourt B.Sc. Co-Founder
Ms. Leslie Auld CPA, M.B.A. Chief Financial Officer
Dr. Melanie Edna Mary Kelly Ph.D. Chief Scientific Officer
Jennifer McCaughey VP of Investor Relations
Ms. Dania Scott B.Sc. Sr. VP of Commercial Strategy
Ms. Aurelia De Pauw Sr. VP of Clinical Programs & Medical Affairs
Mr. Richard Giguere Chief Exec. Officer of Tetra Natural Health Inc.
Randy Ringuette Project Director & Member of Advisory Board

Exchange: OTCQB

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 48.196
Price-to-Sales TTM: 662.0967
IPO Date:
Fiscal Year End: November
Full Time Employees: 33
Back to stocks